GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alkem Laboratories Ltd (NSE:ALKEM) » Definitions » 6-1 Month Momentum %

Alkem Laboratories (NSE:ALKEM) 6-1 Month Momentum % : 12.03% (As of May. 12, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Alkem Laboratories 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-12), Alkem Laboratories's 6-1 Month Momentum % is 12.03%.

The industry rank for Alkem Laboratories's 6-1 Month Momentum % or its related term are showing as below:

NSE:ALKEM's 6-1 Month Momentum % is ranked better than
64.95% of 1107 companies
in the Drug Manufacturers industry
Industry Median: 0.83 vs NSE:ALKEM: 12.03

Competitive Comparison of Alkem Laboratories's 6-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Alkem Laboratories's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkem Laboratories's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkem Laboratories's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Alkem Laboratories's 6-1 Month Momentum % falls into.



Alkem Laboratories  (NSE:ALKEM) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alkem Laboratories  (NSE:ALKEM) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Alkem Laboratories 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Alkem Laboratories's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Alkem Laboratories (NSE:ALKEM) Business Description

Traded in Other Exchanges
Address
Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.

Alkem Laboratories (NSE:ALKEM) Headlines

No Headlines